Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A, Zara F, Canizares J, Koutnikova H, Bidichandani SI, Gellera C, Brice A, Trouillas P, De Michele G, Filla A, De Frutos R, Palau F, Patel PI, Di Donato S, Mandel JL, Cocozza S, Koenig M, Pandolfo M (1996) Friedreich’s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271:1423–1427
Article CAS PubMed Google Scholar
Durr A, Cossee M, Agid Y, Campuzano V, Mignard C, Penet C, Mandel JL, Brice A, Koenig M (1996) Clinical and genetic abnormalities in patients with Friedreich’s ataxia. N Engl J Med 335:1169–1175
Article CAS PubMed Google Scholar
Pandolfo M (2012) Friedreich ataxia. Handb Clin Neurol 103:275–294
Babady NE, Carelle N, Wells RD, Rouault TA, Hirano M, Lynch DR, Delatycki MB, Wilson RB, Isaya G, Puccio H (2007) Advancements in the pathophysiology of Friedreich’s Ataxia and new prospects for treatments. Mol Genet Metab 92:23–35
Article CAS PubMed PubMed Central Google Scholar
Pandolfo M (2009) Friedreich ataxia: the clinical picture. J Neurol 256(Suppl 1):3–8
Chutake YK, Lam C, Costello WN, Anderson M, Bidichandani SI (2014) Epigenetic promoter silencing in Friedreich ataxia is dependent on repeat length. Ann Neurol 76:522–528
Article CAS PubMed PubMed Central Google Scholar
Chutake YK, Costello WN, Lam CC, Parikh AC, Hughes TT, Michalopulos MG, Pook MA, Bidichandani SI (2015) FXN Promoter Silencing in the Humanized Mouse Model of Friedreich Ataxia. PLoS ONE 10:e0138437
Article PubMed PubMed Central Google Scholar
Cossee M, Durr A, Schmitt M, Dahl N, Trouillas P, Allinson P, Kostrzewa M, Nivelon-Chevallier A, Gustavson KH, Kohlschutter A, Muller U, Mandel JL, Brice A, Koenig M, Cavalcanti F, Tammaro A, De Michele G, Filla A, Cocozza S, Labuda M, Montermini L, Poirier J, Pandolfo M (1999) Friedreich’s ataxia: point mutations and clinical presentation of compound heterozygotes. Ann Neurol 45:200–206
Article CAS PubMed Google Scholar
Galea CA, Huq A, Lockhart PJ, Tai G, Corben LA, Yiu EM, Gurrin LC, Lynch DR, Gelbard S, Durr A, Pousset F, Parkinson M, Labrum R, Giunti P, Perlman SL, Delatycki MB, Evans-Galea MV (2016) Compound heterozygous FXN mutations and clinical outcome in friedreich ataxia. Ann Neurol 79:485–495
Article CAS PubMed Google Scholar
McCormack ML, Guttmann RP, Schumann M, Farmer JM, Stolle CA, Campuzano V, Koenig M, Lynch DR (2000) Frataxin point mutations in two patients with Friedreich’s ataxia and unusual clinical features. J Neurol Neurosurg Psychiatry 68:661–664
Article CAS PubMed PubMed Central Google Scholar
Lazaropoulos M, Dong Y, Clark E, Greeley NR, Seyer LA, Brigatti KW, Christie C, Perlman SL, Wilmot GR, Gomez CM, Mathews KD, Yoon G, Zesiewicz T, Hoyle C, Subramony SH, Brocht AF, Farmer JM, Wilson RB, Deutsch EC, Lynch DR (2015) Frataxin levels in peripheral tissue in Friedreich ataxia. Ann Clin Transl Neurol 2:831–842
Article CAS PubMed PubMed Central Google Scholar
Guo L, Wang Q, Weng L, Hauser LA, Strawser CJ, Mesaros C, Lynch DR, Blair IA (2018) Characterization of a new N-terminally acetylated extra-mitochondrial isoform of frataxin in human erythrocytes. Sci Rep 8:17043
Article PubMed PubMed Central Google Scholar
Wang Q, Laboureur L, Weng L, Eskenazi NM, Hauser LA, Mesaros C, Lynch DR, Blair IA (2022) Simultaneous Quantification of Mitochondrial Mature Frataxin and Extra-Mitochondrial Frataxin Isoform E in Friedreich’s Ataxia Blood. Front Neurosci 16:874768
Article PubMed PubMed Central Google Scholar
Deutsch EC, Oglesbee D, Greeley NR, Lynch DR (2014) Usefulness of frataxin immunoassays for the diagnosis of Friedreich ataxia. J Neurol Neurosurg Psychiatry 85:994–1002
Oglesbee D, Kroll C, Gakh O, Deutsch EC, Lynch DR, Gavrilova R, Tortorelli S, Raymond K, Gavrilov D, Rinaldo P, Matern D, Isaya G (2013) High-throughput immunoassay for the biochemical diagnosis of Friedreich ataxia in dried blood spots and whole blood. Clin Chem 59:1461–1469
Article CAS PubMed PubMed Central Google Scholar
Nachbauer W, Wanschitz J, Steinkellner H, Eigentler A, Sturm B, Hufler K, Scheiber-Mojdehkar B, Poewe W, Reindl M, Boesch S (2011) Correlation of frataxin content in blood and skeletal muscle endorses frataxin as a biomarker in Friedreich ataxia. Mov Disord 26:1935–1938
Deutsch EC, Santani AB, Perlman SL, Farmer JM, Stolle CA, Marusich MF, Lynch DR (2010) A rapid, noninvasive immunoassay for frataxin: utility in assessment of Friedreich ataxia. Mol Genet Metab 101:238–245
Article CAS PubMed PubMed Central Google Scholar
Willis JH, Isaya G, Gakh O, Capaldi RA, Marusich MF (2008) Lateral-flow immunoassay for the frataxin protein in Friedreich’s ataxia patients and carriers. Mol Genet Metab 94:491–497
Article CAS PubMed PubMed Central Google Scholar
Steinkellner H, Scheiber-Mojdehkar B, Goldenberg H, Sturm B (2010) A high throughput electrochemiluminescence assay for the quantification of frataxin protein levels. Anal Chim Acta 659:129–132
Article CAS PubMed Google Scholar
Weng L, Wang Q, Yu S, Yang X, Lynch DR, Mesaros C, Blair IA (2019) Evaluation of antibodies for western blot analysis of frataxin protein isoforms. J Immunol Methods 474:112629
Article CAS PubMed PubMed Central Google Scholar
Weng L, Laboureur L, Wang Q, Guo L, Xu P, Gottlieb L, Lynch DR, Mesaros C, Blair IA (2020) Extra-mitochondrial mouse frataxin and its implications for mouse models of Friedreich’s ataxia. Sci Rep 10:15788
Article CAS PubMed PubMed Central Google Scholar
Guo L, Wang Q, Weng L, Hauser LA, Strawser CJ, Rocha AG, Dancis A, Mesaros C, Lynch DR, Blair IA (2018) Liquid chromatography-high resolution mass spectrometry analysis of platelet frataxin as a protein biomarker for the rare disease Friedreich’s Ataxia. Anal Chem 90:2216–2223
Article CAS PubMed PubMed Central Google Scholar
Rojsajjakul T, Wu L, Grady CB, Hwang WT, Mesaros C, Lynch DR, Blair IA (2023) Liquid Chromatography-Mass Spectrometry Analysis of Frataxin Proteoforms in Whole Blood as Biomarkers of the Genetic Disease Friedreich’s Ataxia. Anal Chem 95:4251–4260
Article CAS PubMed PubMed Central Google Scholar
Lynch DR, Farmer JM, Tsou AY, Perlman S, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Wilson RB, Balcer LJ (2006) Measuring Friedreich ataxia: complementary features of examination and performance measures. Neurology 66:1711–1716
Article CAS PubMed Google Scholar
Friedman LS, Farmer JM, Perlman S, Wilmot G, Gomez CM, Bushara KO, Mathews KD, Subramony SH, Ashizawa T, Balcer LJ, Wilson RB, Lynch DR (2010) Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Mov Disord 25:426–432
Article PubMed PubMed Central Google Scholar
Rummey C, Corben LA, Delatycki MB, Subramony SH, Bushara K, Gomez CM, Hoyle JC, Yoon G, Ravina B, Mathews KD, Wilmot G, Zesiewicz T, Perlman S, Farmer JM, Lynch DR (2019) Psychometric properties of the Friedreich Ataxia Rating Scale. Neurol Genet 5:371
Article PubMed PubMed Central Google Scholar
Lichtman MA, Kaushansky K, Prchal JT, Levi MM, Burns LJ, Linch DC (2022) Williams manual of hematology. MgGraw Hill, New York
Palka T, Koteja PM, Tota L, Rydzik L, Kopanska M, Kaczorowska I, Javdaneh N, Mikulakova W, Wolski H, Ambrozy T (2023) The Influence of Various Hydration Strategies (Isotonic, Water, and No Hydration) on Hematological Indices, Plasma Volume, and Lactate Concentration in Young Men during Prolonged Cycling in Elevated Ambient Temperatures. Biology (Basel) 12
Payne RM (2022) Cardiovascular Research in Friedreich ataxia: unmet needs and opportunities. JACC Basic Transl Sci 7:1267–1283
Article PubMed PubMed Central Google Scholar
Long A, Napierala JS, Polak U, Hauser L, Koeppen AH, Lynch DR, Napierala M (2017) Somatic instability of the expanded GAA repeats in Friedreich’s ataxia. PLoS ONE 12:e0189990
Article PubMed PubMed Central Google Scholar
Deutsch EC, Seyer LA, Perlman SL, Yu J, Lynch DR (2012) Clinical monitoring in a patient with Friedreich ataxia and osteogenic sarcoma. J Child Neurol 27:1159–1163
Article PubMed PubMed Central Google Scholar
Plasterer HL, Deutsch EC, Belmonte M, Egan E, Lynch DR, Rusche JR (2013) Development of frataxin gene expression measures for the evaluation of experimental treatments in Friedreich’s ataxia. PLoS ONE 8:e63958
Article CAS PubMed PubMed Central Google Scholar
Seyer L, Greeley N, Foerster D, Strawser C, Gelbard S, Dong Y, Schadt K, Cotticelli MG, Brocht A, Farmer J, Wilson RB, Lynch DR (2015) Open-label pilot study of interferon gamma-1b in Friedreich ataxia. Acta Neurol Scand 132:7–15
Article CAS PubMed Google Scholar
Lynch DR, Hauser L, McCormick A, Wells M, Dong YN, McCormack S, Schadt K, Perlman S, Subramony SH, Mathews KD, Brocht A, Ball J, Perdok R, Grahn A, Vescio T, Sherman JW, Farmer JM (2019) Randomized, double-blind, placebo-controlled study of interferon-gamma 1b in Friedreich Ataxia. Ann Clin Transl Neurol 6:546–553
Comments (0)